Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NL-OMON58269) titled 'Next Gen ECG Board' on Dec. 17, 2025.
Study Type: Observational
Study Design:
N/A: single arm study, Open (masking not used), Uncontrolled, single, treatment
Primary Sponsor: Dragerwerk AG & Co. KGaA
Condition:
Patients admitted at a cardio thorasic Intensive care for hemodynamic monitoring Patients admitted for hemodynamic monitoring
10007521
Intervention:
A Draeger Infinity M540 patient monitor with modified hardware for ECG data processing
Recruitment Status: Not Recruiting
Phase: NA
Date of First Enrollment: 2026-01-18
Target Sample Size: 65
Countries of Recruitment:
Netherlands
To know more, vi...